Accelerator

Automation + Miniaturization = Acceleration

raises the institutional and
research profile of UPOL

develops innovative chemistry for:

unmet medical needs
materials and nanotechnologies of the future
sustainable agriculture

Innovative Chemistry Group

The Innovative Chemistry group will be established on the basis of the ERA Chairs grant awarded within the Horizon Europe ERA Chairs Call. During the course of the next five years, CATRIN will be implementing an absolutely unique project entitled ACCELERATOR, the aim of which is to bring together the world-renowned professor, inventor and innovator, Alexander Dömling, as the ERA Chair, and CATRIN’s all three divisions, merging them into a unique scientific ecosystem.

Alexander Dömling

Alexander Dömling is a world-renowned scientist in the fields of miniaturization, synthetic chemistry automation and multicomponent reaction chemistry. In the first decade of his professional life, which he refers to as his “ learning period“, he studied chemistry and biology at the Technical University of Munich. He received his doctorate from the world-renowned scientist Ivar Ugi. Thanks to the support of the Humboldt Foundation, he spent his postdoctoral period with two-time Nobel laureate Barry Sharpless at the Scripps Research Institute in California. After returning from the US, he founded his first biotechnology company, Morphochem.

Project information

Project Duration
1 February 2023–31 January 2028

Total Cost
2 499 062 EUR

EU Contribution
2 499 062 EUR

Funded by the European Union under project no. 101087318. Views and opinions expressed are however those of the author(s) only and do not necessarily reflect those of the European Union or the European Research Executive Agency. Neither the European Union nor the granting authority can be held responsible for them.